ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 176

Identification Of Major Histocompatibility Complex Class II Alleles Associated With Systemic Sclerosis Through Imputation Strategy

Jose Ezequiel Martin1, Carmen P. Simeón2, Norberto Ortego-Centeno3, Patricia Carreira4, Miguel A. Gonzalez-Gay5,6, Nicolas Hunzelmann7, Shervin Assassi8, Filemon K. Tan8, Frank C. Arnett8, Xiaodong Zhou8, T.R.D.J. Radstake9,10, Maureen D. Mayes11, Paul de Bakker12,13, Javier Martin1,14 and B. P. C. Koeleman13, 1Immunology, Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, Armilla (Granada), Spain, 2Department of Internal Medicine, Hospital Valle de Hebron, Barcelona, Spain, 3Systemic Autoimmune Diseases Unit, Hospital Clínico San Cecilio, Granada, Spain, 4Hospital Universitario 12 de Octubre, Department of Rheumatology, Madrid, Spain, 5Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, Rheumatology Division, IFIMAV, Santander, Spain, 6Rheumatology, Hospital Universitario Marqués de Valdecilla. IFIMAV, Santander, Spain, 7Department of Dermatology, University of Cologne, Cologne, Germany, 8Rheumatology, University of Texas Health Science Center at Houston, Houston, TX, 9Laboratory for Translational Immunology, UMC Utrecht, Utrecht, Netherlands, 10Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 11University of Texas Health Science Center at Houston, Houston, TX, 12Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 13Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands, 14Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN-CSIC), Granada, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: GWAS, human leukocyte antigens (HLA), major histocompatibility complex (MHC) and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Different alleles of MHC class II molecules have been associated either with risk to systemic sclerosis (SSc) or its subphenotypes. Due to the high cost of HLA typing, studies have been limited to small sample sizes, preventing definitive statements as to which HLA alleles are likely causal.

Methods:

We have imputed the MHC class I and II alleles of 2,296 cases and 5,356 controls from four countries with a method previously developed. Besides classical HLA alleles, we also imputed amino acid changes encoded by genetic variants within the different MHC molecules. We compared the frequencies of the different alleles between cases and controls for SNPs, amino acids and classical HLA alleles.

Results:

The accuracy of the imputations ranged from 84% to 94% depending on the alleles being imputed with an average of 92% for all alleles in both populations. We confirmed previous associations of HLA alleles with SSc or its auto-antibody positive subgroups (e.g. HLA-DRB1*0701, HLA-DPB1*1301, HLA-DRB1*1104, HLA-DQB1*0501). We define in deeper detail some of these associations down to the level of aminoacidic positions which affect epitope binding and relocate some previous SSc associations within auto-antibody positive subgroups. Furthermore, we describe new association of the HLA allele HLA-DRB1*0801 with the presence of anti-centromere auto-antibodies. 

Conclusion:

Our data indicate that most HLA associations are specific to the presence of auto-antibodies. Also, only MHC class II alleles are associated and not MHC class I.


Disclosure:

J. E. Martin,
None;

C. P. Simeón,
None;

N. Ortego-Centeno,
None;

P. Carreira,
None;

M. A. Gonzalez-Gay,
None;

N. Hunzelmann,
None;

S. Assassi,
None;

F. K. Tan,
None;

F. C. Arnett,
None;

X. Zhou,
None;

T. R. D. J. Radstake,
None;

M. D. Mayes,
None;

P. de Bakker,
None;

J. Martin,
None;

B. P. C. Koeleman,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/identification-of-major-histocompatibility-complex-class-ii-alleles-associated-with-systemic-sclerosis-through-imputation-strategy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology